本文關鍵詞： 原發(fā)性肝癌 經(jīng)導管肝動脈化療栓塞 CT MRI　出處：《實用醫(yī)學雜志》2017年18期 　論文類型：期刊論文

【摘要】：目的比較CT及MRI對原發(fā)性肝癌經(jīng)導管肝動脈化療栓塞(TACE)術后療效評估的價值。方法以45例原發(fā)性肝癌患者為研究對象,入選患者均采用TACE治療3~5次,治療后行CT、MRI病灶檢查及數(shù)字減影血管造影檢查,以數(shù)字減影血管造影檢查作為比較標準,分析CT及MRI檢查的病灶殘余或病灶復發(fā)結果及腫瘤病灶包膜檢出情況。結果 TACE術后病灶殘余或病灶復發(fā)的掃描準確率和掃描敏感性方面,CT掃描顯著低于MRI掃描,差異具有統(tǒng)計學意義(P0.05);TACE術后腫瘤包膜檢出率方面,CT掃描顯著低于MRI掃描,差異具有統(tǒng)計學意義(P0.05);TACE術后不同類型碘油沉積病灶殘余或病灶復發(fā)的檢出率方面,CT掃描顯著低于MRI掃描,差異具有統(tǒng)計學意義(P0.05)。結論與CT檢查方式比較,MRI檢測在TACE術后病灶殘余或病灶復發(fā)有著較高的的準確率和敏感性,不僅可有效顯示腫瘤包膜情況,也檢測出不同類型碘油沉積的病灶殘余或病灶復發(fā),MRI對原發(fā)性肝癌TACE術后的療效評估優(yōu)于CT對原發(fā)性肝癌TACE術后的療效評估。
[Abstract]:Objective to compare the value of CT and MRI in evaluating the curative effect of transcatheter hepatic artery chemoembolization (TACEE) for primary liver cancer. All the patients were treated with TACE for 5 times. After the treatment, the focus of TACE and digital subtraction angiography were examined, and digital subtraction angiography was taken as the comparative standard. Results the accuracy and sensitivity of CT and MRI in the detection of residual or recurrent lesions and the detection of tumor capsule were analyzed. Results the accuracy and sensitivity of CT and MRI in detecting residual lesions or recurrence of lesions were analyzed. Ct scan was significantly lower than MRI scan, the difference was statistically significant (P 0.05). The detection rate of tumor capsule after TACE was significantly lower than that of MRI, and the difference was statistically significant (P 0.05). The detection rate of residual or recurrence of different types of lipiodol deposits after TACE was significantly lower than that of MRI. Conclusion compared with CT, MRI has a higher accuracy and sensitivity in detecting residual or recurrent lesions after TACE. Not only can the tumor capsule be effectively displayed, but also the residual or recurrent lesions of different types of lipiodol deposits can be detected. MRI was better than CT in evaluating the curative effect of TACE for primary liver cancer.
【作者單位】： 四川省醫(yī)學科學院·四川省人民醫(yī)院放射科;
【分類號】：R445.2;R730.44;R735.7
【正文快照】： 原發(fā)性肝癌是繼胃癌和食管癌后的第三大惡性腫瘤,全球年新增病例可高達60萬人,我國的原發(fā)性肝癌占比世界的50%以上,是嚴重威脅我國人民生命安全的疾病[1]。原發(fā)性肝癌具有明顯癥狀時一般都處于中晚期,且此時80%的患者均已不適合手術切除治療和化療,經(jīng)導管肝動脈化療栓塞(TACE)

【相似文獻】

相關期刊論文 前10條

1 陳似霞;鐘麗;梁麗宏;蔣金利;;沙培林碘化油乳劑治療原發(fā)性肝癌的觀察與護理[J];中國癌癥防治雜志;2010年02期

2 王美書;張傳華;;原發(fā)性肝癌行肝動脈化療栓塞術后的并發(fā)癥觀察及護理[J];中國醫(yī)藥導報;2011年15期

3 張尚林;余業(yè)洗;;原發(fā)性肝癌自發(fā)破裂一例[J];中級醫(yī)刊;1958年01期

4 佃雪，

本文編號：1475064